Clinical Trials for SLE (Systemic Lupus)

Find clinical trials for sle (systemic lupus). Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

NCT ID: NCT06613360

This clinical trial is studying a new treatment called CLN-978, which is designed to help people with moderate to severe Systemic Lupus Erythematosus (SLE). SLE is an autoimmune disease where the b...

Recruiting

Phase: PHASE1 Type: interventional Locations: Webster, Texas, United States, Orlando, Florida, United States +12 more

DR-0201 in Subjects With Autoimmune Diseases

NCT ID: NCT06647069

This clinical trial, called DR-0201, is looking at a new treatment for people with certain autoimmune diseases, including systemic lupus erythematosus (SLE), cutaneous lupus, Sjögren's syndrome, an...

Recruiting

Phase: PHASE1 Type: interventional Locations: Adelaide, South Australia, Australia, Coorparoo, Queensland, Australia +20 more

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

NCT ID: NCT06971913

This clinical trial is looking at how effective and safe a low-dose treatment called interleukin-2 (IL-2) is for patients with systemic lupus erythematosus (SLE) who also have a viral infection kno...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT ID: NCT06925542

This clinical trial is studying a new treatment called CTX112 for adults who have certain autoimmune diseases that are difficult to manage, such as systemic lupus erythematosus (SLE), systemic scle...

Recruiting

Phase: PHASE1 Type: interventional Locations: Redwood City, California, United States, Chicago, Illinois, United States +5 more

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

NCT ID: NCT06294236

The GLEAM trial is a research study looking at a new treatment called SC291 for people with severe autoimmune diseases, such as lupus and certain types of vasculitis. This Phase 1 trial aims to und...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Atlanta, Georgia, United States +3 more

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

NCT ID: NCT06548607

This clinical trial is studying a new treatment called RD06-04, which is a type of targeted therapy designed to help patients with autoimmune diseases such as Systemic Lupus Erythematosus (SLE), Sy...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Bengbu, Anhui, China

Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity

NCT ID: NCT06610409

This clinical trial is looking at a specific substance in the blood called CXCL5 to see how it relates to the level of disease activity in patients with Systemic Lupus Erythematosus (SLE), an autoi...

Not yet recruiting

Type: observational Locations: Assuit, Dairuit, Egypt

A Study of RD06-04 in Patients With Active Autoimmune Diseases

NCT ID: NCT06548620

This clinical trial is studying a new treatment called RD06-04 for patients with various autoimmune diseases, which are conditions where the body's immune system mistakenly attacks its own tissues....

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Zhengzhou, Henan, China

Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

NCT ID: NCT06150651

This clinical trial is studying a new treatment approach for patients with Systemic Lupus Erythematosus (SLE), a serious autoimmune disease where the body's immune system attacks its own tissues. S...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bangkok, Please Select, Thailand

Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients

NCT ID: NCT06063668

This clinical trial is studying a substance called autotaxin (ATX) in patients with Systemic Lupus Erythematosus (SLE), which is a condition that affects the immune system. The researchers want to ...

Not yet recruiting

Type: observational

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

NCT ID: NCT06056921

This clinical trial is investigating a new treatment called CD19 targeted CAR-T therapy for patients suffering from certain autoimmune diseases, including Systemic Lupus Erythematosus (SLE), Sjogre...

Recruiting

Phase: PHASE1 Type: interventional Locations: Taiyuan, Shanxi, China

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia

NCT ID: NCT04604990

This clinical trial, called the National Systemic Lupus Erythematosus Prospective Cohort in Saudi Arabia, aims to better understand systemic lupus erythematosus (SLE), a complex autoimmune disease....

Recruiting

Type: observational Locations: Riyadh, , Saudi Arabia, Riyadh, Central Province, Saudi Arabia

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions